EBOSY logo
OTC · EBOSYMedical - DistributionUpdated Nov 5, 2026

EBOS Group Limited ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for EBOS Group Limited (EBOSY) is 7.99%

According to EBOS Group Limited’s latest financial reports and current stock price. The company's current ROE is 7.99%. This represents a change of 95.45% compared to the average of 4.09% of the last 4 quarters.

EBOS Group Limited (EBOSY) Historical ROE (quarterly & annually)

How has EBOSY ROE performed in the past?

The mean historical ROE of EBOS Group Limited over the last ten years is 10.69%. The current 7.99% ROE has changed -25.30% with respect to the historical average. Over the past ten years (40 quarters), EBOSY's ROE was at its highest in in the December 2018 quarter at 6.88%. The ROE was at its lowest in in the June 1999 quarter at 0%.

Quarterly (TTM)
Annual

Average

10.69%

Median

11.07%

Minimum

7.79%

Maximum

13.13%

EBOS Group Limited (EBOSY) ROE by Quarter and Year

Discovering the peaks and valleys of EBOS Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 16.35%

Maximum Annual ROE = 13.13%

Minimum Annual Increase = -31.88%

Minimum Annual ROE = 7.79%

Quarterly (TTM)
Annual
YearROEChange
20267.79%-0.78%
20257.85%-28.97%
202411.06%6.22%
202310.41%16.35%
20228.95%-31.88%
202113.13%6.25%
202012.36%11.51%
201911.08%-11.59%
201812.54%6.84%
201711.73%0.47%

EBOS Group Limited (EBOSY) Average ROE

How has EBOSY ROE performed in the past?

The current ROE of EBOS Group Limited (EBOSY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.90%

5-year avg

9.21%

10-year avg

10.69%

EBOS Group Limited (EBOSY) ROE vs. Peers

How is EBOSY’s ROE compared to its peers?

EBOS Group Limited’s ROE is less than MediPal Holdings Corporation (7.26%), less than Sinopharm Group Co. Ltd. (8.33%), less than Alfresa Holdings Corporation (7.93%), less than Cencora, Inc. (115.76%), greater than Cardinal Health, Inc. (-59.73%), greater than McKesson Corporation (-1423.16%), less than 111, Inc. (23.64%), less than Accendra Health, Inc. (63.40%),

Build a custom stock screener for EBOS Group Limited (EBOSY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like EBOS Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

EBOS Group Limited (EBOSY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like EBOS Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is EBOS Group Limited's ROE?

How is the ROE calculated for EBOS Group Limited (EBOSY)?

What is the highest ROE for EBOS Group Limited (EBOSY)?

What is the 3-year average ROE for EBOS Group Limited (EBOSY)?

What is the 5-year average ROE for EBOS Group Limited (EBOSY)?

How does the current ROE for EBOS Group Limited (EBOSY) compare to its historical average?